Addendum to Commission A09-02 (Prasugrel for Acute Coronary Syndrome) [Internet].

In its letter of September 15, 2011, the Federal Joint Committee (G-BA) commissioned the Institute for Quality and Efficiency in Health Care (IQWiG) to provide further information about the Final Report A09-02 (Prasugrel for acute coronary syndrome (ACS)). Information was requested about the H7T-MC-TACM study mentioned on Page 130 of the Final Report, particularly a specific description of the study design and an answer to the question whether the H7T-MC-TACM study has effects on the assessment, already undertaken by IQWiG, of clopidogrel plus acetylsalicylic acid (ASA) in ACS (A04-01B).

http://ift.tt/2t2j9VF